About
Think Liver Think Life® is American Liver Foundation’s (ALF) nationwide public health initiative raising awareness and screening U.S. adults for steatotic (fatty) liver disease and liver cancer. Our goal is to ensure every American understands their risk for liver disease, receives the appropriate liver screening test and feels well-informed and supported throughout their liver journey.
We partner with Free & Charitable Clinics, Federally Qualified Health Centers, health departments, faith‑based and community organizations, and other voluntary health groups nationwide to deliver free liver screenings to uninsured and underinsured populations at greatest risk. ALF also participates in community events nationwide throughout the year to raise awareness and educate the public about the importance of liver health.
Take the quiz
Liver disease affects approximately 100 million Americans. An estimated 80-100 million people in the US have some form of fatty liver disease (now called steatotic liver disease). Certain other health conditions can put people at higher risk for developing fatty liver disease. Take this quiz to see whether you or a loved one could be at risk for fatty liver disease, which usually has no symptoms unless or until liver damage becomes worse.
Contributing Sponsors
- Alexion Pharmaceuticals
- AbbVie
- Blue Cross Blue Shield of Texas
- Eisai Inc.
- Genentech
- Grifols
- Regeneron Pharmaceuticals, Inc.



















































